125 related articles for article (PubMed ID: 15964599)
1. Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil.
Marier JF; Deschênes JL; Hage A; Seliniotakis E; Gritsas A; Flarakos T; Beaudry F; Vachon P
Life Sci; 2005 Oct; 77(23):2911-26. PubMed ID: 15964599
[TBL] [Abstract][Full Text] [Related]
2. Influence of concomitant quinidine administration on dextromethorphan disposition in rats.
Marier JF; Pope LE; Yakatan GJ; Berg JE; Stiles M; Vachon P
J Vet Pharmacol Ther; 2004 Apr; 27(2):111-4. PubMed ID: 15096109
[TBL] [Abstract][Full Text] [Related]
3. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
4. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
[TBL] [Abstract][Full Text] [Related]
5. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
6. P glycoprotein regulated transport of glutamate at blood brain barrier.
Liu XD; Liu GQ
Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
[TBL] [Abstract][Full Text] [Related]
7. Role of P-170 glycoprotein in colchicine brain uptake.
Drion N; Risede P; Cholet N; Chanez C; Scherrmann JM
J Neurosci Res; 1997 Jul; 49(1):80-8. PubMed ID: 9211992
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.
Pope LE; Khalil MH; Berg JE; Stiles M; Yakatan GJ; Sellers EM
J Clin Pharmacol; 2004 Oct; 44(10):1132-42. PubMed ID: 15342614
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
10. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
Chikhale EG; Burton PS; Borchardt RT
J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780
[TBL] [Abstract][Full Text] [Related]
11. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.
Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD
Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677
[TBL] [Abstract][Full Text] [Related]
13. Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain.
Hankø E; Tommarello S; Watchko JF; Hansen TW
Pediatr Res; 2003 Oct; 54(4):441-5. PubMed ID: 12904601
[TBL] [Abstract][Full Text] [Related]
14. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
Fujii S; Setoguchi C; Kawazu K; Hosoya K
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4650-8. PubMed ID: 24985475
[TBL] [Abstract][Full Text] [Related]
15. The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice.
Kemper EM; Cleypool C; Boogerd W; Beijnen JH; van Tellingen O
Cancer Chemother Pharmacol; 2004 Feb; 53(2):173-8. PubMed ID: 14605863
[TBL] [Abstract][Full Text] [Related]
16. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.
Wu D; Otton SV; Kalow W; Sellers EM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1431-7. PubMed ID: 7562518
[TBL] [Abstract][Full Text] [Related]
17. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
[TBL] [Abstract][Full Text] [Related]
18. The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition.
Scott JA; Wood M; Flood P
Anesth Analg; 2006 Sep; 103(3):742-6. PubMed ID: 16931690
[TBL] [Abstract][Full Text] [Related]
19. Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?
Clarke G; O'Mahony SM; Cryan JF; Dinan TG
Hum Psychopharmacol; 2009 Apr; 24(3):217-23. PubMed ID: 19212940
[TBL] [Abstract][Full Text] [Related]
20. Influence of erythromycin on the pharmacokinetics of ximelagatran may involve inhibition of P-glycoprotein-mediated excretion.
Eriksson UG; Dorani H; Karlsson J; Fritsch H; Hoffmann KJ; Olsson L; Sarich TC; Wall U; Schützer KM
Drug Metab Dispos; 2006 May; 34(5):775-82. PubMed ID: 16455803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
